7 results
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... Infections of the Skin ... #IDSA #Treatment ... #management #antibiotics ... #pharmacology
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... Community-Acquired Pneumonia ... fluoroquinolone #IDSA ... #Antibiotics #Treatment ... Management #Guidelines #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... against Pneumocystis pneumonia ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
(Such As Focal Pneumonia ... Infection (Diffuse Pulmonary ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... Prevention and Treatment ... of Pneumocystis Pneumonia ... opportunistic #infections #HIVAIDS ... #management #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... Usual interstitial pneumonia ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... involvement of skin ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology